Dr. Michael Menke is President of Value Creation Associates, a decision consulting firm assisting a wide range of companies with strategy development, decision making and portfolio management.

Formerly he was the Chief Portfolio Advocate for HP, advising executives and working teams at all levels and in all segments of HP on strategy development, portfolio management, decision making and new business creation.

Before joining HP he was a founding partner of Strategic Decisions Group, a consultancy where many of the portfolio management approaches in use today by leading companies were initially developed. He has consulted with Abbott, Alcoa, Amgen, AT&T, Bayer, Chevron, Dow, DuPont, Exxon, Ford, GSK, HP, IBM, J&J, Koc Group, Lilly, Mitsubishi, Monsanto, Novartis, P&G, Pfizer, Roche, Shell, Sumitomo Electric, Takeda, TI, Unilever et al. on strategy, major decisions and/or portfolio management. He has also led hundreds of executive seminars and workshops on these topics.

He is a founding member of the Enterprise Portfolio Management Council and has also been an invited speaker at dozens of international conferences on portfolio management, innovation, R&D/technology and business strategy and decision making over the past 25 years. He has recently been leading a groundbreaking international benchmarking study on portfolio management best practices.